Pitavastatin Shortage Update: What Patients Need to Know in 2026

If you take pitavastatin (Livalo or Zypitamag) for high cholesterol, you may have wondered whether there's a shortage affecting your prescription. Here's a clear, up-to-date picture of pitavastatin availability in 2026 — including why some patients still struggle to fill it even without a formal shortage declaration.

Current Pitavastatin Shortage Status in 2026

As of 2026, pitavastatin is NOT listed on the FDA Drug Shortage Database or the ASHP Drug Shortages Resource Center. There is no official national shortage of pitavastatin. The drug is manufactured by multiple companies and is commercially available.

However — and this is critical — the absence of a formal shortage does not mean every pharmacy stocks it. Many patients report difficulty filling pitavastatin prescriptions due to factors unrelated to manufacturing. Understanding those factors is key to knowing what to do next.

Why Pitavastatin Is Still Hard to Find at Some Pharmacies

Several real-world factors create availability problems for pitavastatin patients even without a declared shortage:

• Low prescription volume: Pitavastatin is prescribed far less than atorvastatin or rosuvastatin, so many pharmacies stock it in minimal quantities or not at all.
• Insurance exclusions: Most Medicare Part D and commercial insurance plans do not cover pitavastatin, or place it on a high-cost tier — reducing patient fills and therefore pharmacy reorder frequency.
• Generic market fragmentation: Multiple generic manufacturers mean pharmacy purchasing varies. Your usual pharmacy may carry Manufacturer A's version, while another carries Manufacturer B's. Either way, the drug is therapeutically equivalent.
• Strength-specific stocking: The 2 mg tablet is most commonly stocked. The 1 mg and 4 mg tablets may require special ordering, adding 24-48 hours to your wait.

A Brief History of Pitavastatin Availability

Pitavastatin was first FDA-approved in 2009 under the brand name Livalo, manufactured by Kowa Pharmaceuticals America. For years, it was available only as the brand-name Livalo, making it expensive and limiting its use to patients with specific clinical indications where its advantages justified the cost.

Generic pitavastatin has since become available from multiple manufacturers, broadening access and reducing cost significantly. However, this has also introduced the supply chain fragmentation described above. The drug has not historically been subject to the kind of manufacturing-driven national shortages that affect medications like Adderall or semaglutide.

What Patients Should Do Right Now

If you're having trouble filling a pitavastatin prescription, here's your action plan:

1. Don't stop taking the medication without consulting your doctor. Abrupt discontinuation of statins can temporarily rebound LDL levels. If you're running low, call your doctor today.
2. Ask your pharmacist to place a special order. Most pharmacies can order pitavastatin within 24-48 hours even if it's not on their shelf.
3. Use medfinder to search nearby pharmacies. medfinder calls pharmacies near you to find which ones have your medication in stock, then texts you the results.
4. Explore the Livalo Savings Program. If you're on brand Livalo, eligible patients can pay as little as $25/month. Call 844-567-9504 for details.
5. Consider a mail-order pharmacy. Cost Plus Drugs, Amazon Pharmacy, and your insurance's mail-order option may have more reliable stock.
6. Talk to your doctor about alternatives if access issues persist. Atorvastatin and rosuvastatin are widely available and may be appropriate bridge medications.

39,018+ patients found their medications in stock

39K+

Find Pitavastatin In Stock Today →

Should I Be Worried About Pitavastatin Availability Long-Term?

Based on available information in 2026, there is no reason to expect a significant supply disruption for pitavastatin. The generic market is established, multiple manufacturers are producing it, and the drug is not subject to the same high-demand pressures as medications like GLP-1 agonists or ADHD drugs.

The structural issue — lower stocking levels at individual pharmacies — is a permanent feature of pitavastatin's market position rather than a temporary shortage. Patients on long-term pitavastatin therapy benefit from proactive pharmacy selection: choosing a larger pharmacy or mail-order service that reliably stocks the medication.

Related reading: Why Is Pitavastatin So Hard to Find? [Explained for 2026]